DME competitive bidding
This article was originally published in The Gray Sheet
Executive Summary
Diabetes product manufacturers favor administrative route over legislation to convince CMS that glucose monitors are sufficiently distinct from other durable medical equipment, prosthetics, orthotics and supplies to be omitted from products eligible for competitive bidding when the agency releases a notice of proposed rulemaking this summer. CMS' Program Oversight & Advisory Committee meets in Baltimore Feb. 28-March 2 to mull recommendations for implementing the program. Diabetes management firms also will work with Secretary of Veterans Affairs Jim Nicholson, sworn in Feb. 1, against procurement standardization of the products (1"The Gray Sheet" July 5, 2004, p. 3)...